MedTrace Logo

Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients

NCT07234526 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-11-19

No results posted yet for this study

Summary

To determine whether glucose fluctuations prior to antibiotic administration are associated with sepsis severity and poor clinical outcomes.

* To assess if the time to Glycemic Normalization after Antibiotic Initiation can be used as an Early Prognostic Indicator in Sepsis.
* To evaluate the Glycemic Shock Index (GSI) as a Combined Marker of Hemodynamic and Metabolic Stress in ICU Sepsis Patients.

Conditions

  • Glucose Fluctuations in Sepsis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Muhammad Abbas Al masry, Doctorate of internal medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-12-01
Primary Completion
2028-12-01
Completion
2029-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07234526 on ClinicalTrials.gov